TSI Corp. sales and marketing update

TSIN's preclinical and clinical testing services posted revenues of $11.4 million for the fourth quarter ended June 27 versus revenues of $7.6 million in the fourth quarter last year. TSIN's net loss was $5.1 million (25 cents per share) on revenues of $14.9 million compared to a net loss of $7.1 million (35 cents) on revenues of $11.2 million last year. The 1993 quarter included a $5 million disposal-of-operations charge relating to the net assets of IBR Forschungs GmbH; the 1992 quarter included $4.5 million in one-time charges and adjustments. ...